US FDA clears investigational drug application for UKidney xenotransplantation trial
United Therapeutics has announced that the US Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to initiate a clinical...
Enrolment completed in Japanese phase III trial of sparsentan for IgA nephropathy
Renalys Pharma has completed patient enrolment for its registrational phase III clinical trial of sparsentan for the treatment of IgA nephropathy in Japan.
In April...
Paragonix announces first-in-human use of KidneyVault renal perfusion system
Paragonix Technologies has announced the completion of the first-in-human cases utilising the US Food and Drug Administration (FDA)-cleared KidneyVault portable renal perfusion system.
The cases...
Ozempic picks up FDA indication to treat chronic kidney disease
Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of kidney disease worsening, kidney...
